Cigna Group vs Regeneron Pharmaceuticals
Cigna Group (CI), health care, and Regeneron Pharmaceuticals (REGN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Regeneron Pharmaceuticals is worth $99.6B on the stock market and Cigna Group $78.3B: Regeneron Pharmaceuticals is valued at 27% more. Cigna Group trades at 13.1 times earnings and Regeneron Pharmaceuticals at 21.3; operating margins in their latest fiscal years were 3.35% and 24.9%. Over the past year Cigna Group's share price has moved +10.1% and Regeneron Pharmaceuticals's +31.3%.
Key facts
- Cigna Group market value
- $78.3B
- Regeneron Pharmaceuticals market value
- $99.6B
- Cigna Group P/E
- 13.1
- Regeneron Pharmaceuticals P/E
- 21.3
- Cigna Group revenue
- $274.9BFY to 2025-12-31
- Regeneron Pharmaceuticals revenue
- $14.3BFY to 2025-12-31
- Superinvestors holding both
- 4
Market values as of .
| Measure | Cigna Group | Regeneron Pharmaceuticals |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $78.3Blower | $99.6Bhigher |
| Revenue | $274.9Bhigher | $14.3Blower |
| Earnings | $6Bhigher | $4.5Blower |
| Employees | 65,669higher | 15,410lower |
| Total assets | $157.9Bhigher | $40.6Blower |
| Valuation | ||
| P/E | 13.1lower | 21.3higher |
| P/S | 0.3lower | 6.9higher |
| P/B | 1.8lower | 2.9higher |
| Dividend yield | 2.06%higher | 0.39%lower |
| Profitability | ||
| Operating margin | 3.35%lower | 24.9%higher |
| Balance sheet | ||
| Net assets | $41.7Bhigher | $31.3Blower |
| Total liabilities | $116Bhigher | $9.3Blower |
| Total debt | $31.5Bhigher | $2Blower |
| Cash on hand | $7.7Bhigher | $3.1Blower |
| Price change | ||
| Today | -1.05%lower | +1.10%higher |
| 1 year | +10.1%lower | +31.3%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (4)
- Dodge & Cox team1.8% / 1.9%
- Jeremy Grantham (co-founder)1.5% / 0.1%
- Josef Lakonishok0.3% / 0.3%
- John Overdeck and David Siegel (founders)0.3% / 0.5%
Cigna Group only (11)
- Anthony Bozza6.0%
- Andrew Wellington2.8%
- Lew Sanders2.7%
- Christopher Davis2.7%
- Larry Robbins2.3%
- Charles Brandes (founder)1.7%
- Louis Bacon0.8%
- David Einhorn0.6%
- Richard Pzena0.4%
- Tweedy, Browne team0.2%
- Rajiv Jain<0.1%
Regeneron Pharmaceuticals only (6)
- Mason Hawkins5.0%
- Harry Burn3.0%
- Jim Simons (1938–2024)0.3%
- Cliff Asness0.2%
- Joel Greenblatt0.2%
- Ray Dalio (founder)0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Cigna Group / Regeneron Pharmaceuticals). Who owns CI · Who owns REGN
More on Cigna Group
Further comparisons
Cigna Group against its closest peers
Regeneron Pharmaceuticals against its closest peers
Learn
Questions and answers
Which is bigger, Cigna Group or Regeneron Pharmaceuticals?
By market value, Regeneron Pharmaceuticals is the larger: $99.6B against $78.3B for Cigna Group. By revenue in its latest fiscal year, Cigna Group is the larger: $274.9B against $14.3B for Regeneron Pharmaceuticals.
Which has the higher P/E ratio?
Regeneron Pharmaceuticals: 21.3, against 13.1 for Cigna Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Regeneron Pharmaceuticals: 24.9%, against 3.35% for Cigna Group. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Cigna Group: 2.06%, against 0.39% for Regeneron Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Cigna Group: $31.5B, against $2B for Regeneron Pharmaceuticals. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Cigna Group and Regeneron Pharmaceuticals?
In their latest 13F filings, Dodge & Cox team, Jeremy Grantham (co-founder), Josef Lakonishok and John Overdeck and David Siegel (founders) hold both.
Cite this page
Funkfolio, “Cigna Group vs Regeneron Pharmaceuticals”, data as of 17 November 2026. https://funkfolio.com/compare/ci-vs-regn
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.